4th Annual Early Stage Product Development and Commercialization Strategies for the Bio/Pharmaceutical and Medical Device Industries
February 25 – 26, 2008 * Location TBD
For more information or to register, please visit the conference website.
Visit this Pharma Marketing Events Forum discussion thread for up-to-date notices, program details, speaker changes, etc.
The development of new drugs continues to be a long and expensive process. Companies are under pressure to re-evaluate their product development process. By implementing effective strategies for early stage commercialization companies can maximize efficiency, bring products to the market quicker and identify product assessments early on development.
Key topics being researched for 2008 include:
- Portfolio prioritization and analysis
- Implementation of early pricing models
- Incorporation of reimbursement strategies into early commercialization
- Early market research/preparation
A Sampling of Companies that have Benefited from our Previous Early Stage Product Development and Commercialization Strategies Conference:
3M Pharmaceuticals * Abbott Labs * Advantage Grey Grey Healthcare Group * Allergan * ALZA Corp * Amgen Inc * Amylin Pharmaceuticals * Analytica Grp * AriVan Research LLC * AstraZeneca * Bausch & Lomb * Beckman HHC * Berlex Inc * Beyond Complexity Ventures LLC * BioPharma Business Development * Biovail * Bristol Myers Squibb Co * Burnside Communications * Campbell Alliance * Cardinal Health * Centocor Inc * Cline Davis & Mann Inc * CombinatoRx * Cordis Corp * Johnson & Johnson Co * CSL Behring * Cutting Edge Info * Daiichi Sankyo Inc * DDN Pharmaceutical Logistics * Decision Strategies * Delphi Pharma * Duramed Pharmaceuticals Inc * Eisai Inc * Elan Pharmaceuticals * Eli Lilly & Co * Endo Pharmaceuticals * Enturia Inc * Enzo Therapeutics Inc * Enzon Pharmaceuticals Inc * Exaeris * Fishbein Associates * Forest Labs Inc * Fort Dodge Animal Health * Frankel Group LLC * Genactis, Inc * Genentech * Genzyme * GlaxoSmithKline * Grey Healthcare Group * Guilford Pharmaceuticals * Harvard * Healogix LLC * HealthStat * HillCo Partners * Hoffmann La Roche * Human Genome Sciences * i3 Innovus * i3 Magnifi * ICOS Corp * IMS Health * Invitrogen * Jazz Pharmaceuticals Inc * Johnson & Johnson * KDS Consulting LLC * KPMG LLP * KV Pharmaceutical Co * LungRx * Mannkind Corp * Mattson Jack Group * Maxiom Consulting Group Inc * Medical Intelligence Solutions * MedImmune Inc * Millennium Pharmaceuticals Inc * MME LLC * Neurochem Inc * Neurocrine Biosciences * Novartis Pharmaceuticals Corp * Novo Nordisk Inc * OraPharma Inc * Ortho Biotech * PDI Inc * PDL BioPharma * Penwest Pharmaceuticals Co * Pfizer Inc * Pharma Marketing News * Pharmaceutical Institute * Pharmion Corp * Prince Edward Island Business Dev Inc * Roche Labs Inc * Rogers Medical Intelligence Solutions * sanofi aventis * Sepracor Inc * Siegfried USA Inc * SmartAnalyst * St Josephs University * Strategic Decisions Group * Sunesis Pharmaceuticals * Takeda Pharmaceuticals * Talecris Biotherapeutics Inc * TAP Pharmaceutical Products Inc * TCG BioPharma * Tolerx * Tormey Consulting Group * Trinity Partners & Akuta Corp * UCB Pharma * United BioSource Corp * United Therapeutics Corp * VI Technologies * Waife & Associates * Wyeth * Xanodyne Pharmaceuticals Inc * Xcenda * XOMA Ltd
For more information or to register, please please visit the conference website or contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at email@example.com.